Working... Menu
Trial record 16 of 3695 for:    aging

Aging, Cognition, and Hearing Evaluation in Elders Study (ACHIEVE-P)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02412254
Recruitment Status : Active, not recruiting
First Posted : April 9, 2015
Last Update Posted : February 11, 2019
Information provided by (Responsible Party):
Johns Hopkins University

Brief Summary:
The investigators will conduct a small pilot study that will randomize ~ 40 70-84 year-old adults with hearing loss to best-practices hearing rehabilitative treatment (hearing assessment, counseling, fitting of amplification devices) versus a successful aging intervention (one-on-one counseling/education sessions on successful aging topics). Participants will be followed for 6 months, and outcomes will focus on communication, quality of life, cognition, and other functional surveys. This pilot study is in preparation for a larger planned trial to investigate if hearing loss treatment can reduce cognitive decline and dementia in older adults.

Condition or disease Intervention/treatment Phase
Hearing Loss Other: Best practices hearing rehabilitative treatment Other: Successful aging intervention Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 40 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Aging, Cognition, and Hearing Evaluation in Elders Pilot Study
Study Start Date : May 2015
Estimated Primary Completion Date : June 2019
Estimated Study Completion Date : June 2019

Resource links provided by the National Library of Medicine

Arm Intervention/treatment
Active Comparator: Hearing intervention
Best practices hearing rehabilitative treatment
Other: Best practices hearing rehabilitative treatment
Intervention comprises hearing needs assessment, counselling, sensory management with amplification devices, and rehabilitative training.

Placebo Comparator: Successful aging intervention
Successful aging intervention
Other: Successful aging intervention
One-on-one education sessions on healthy aging topics (cancer screening, smoking cessation, etc.) between a trainer and participant

Primary Outcome Measures :
  1. Hearing Handicap Inventory for the Elderly (HHIE) [ Time Frame: 6 month follow-up ]

Secondary Outcome Measures :
  1. Neurocognitive test battery including Trail Making Test, Delayed Word Recall, and other tests [ Time Frame: 6 months ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   70 Years to 84 Years   (Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria

  • Age 70-84 years.
  • Community-dwelling.
  • Fluent English-speaker.
  • Residency. Participants must plan to reside in the local area for the study duration (6 months).
  • Audiometric hearing impairment. Participants must have adult-onset hearing impairment with a pure tone average (0.5, 1, and 2 kHz) in the better-hearing ear of ≥ 30 decibels and <70 dB.
  • Word Recognition in Quiet score >60% bilaterally.
  • Mini-Mental State Exam (MMSE) score ≥ 23 for individuals with high-school degree or less; Mini-Mental State Exam (MMSE) score ≥ 25 for individuals with some college or more
  • Willingness to participate. Participants must be willing and able to consent to participate in the study, be willing to be randomized to either the Hearing intervention or to the Successful Aging intervention, and be willing to follow the study protocol for the duration of the trial.

Exclusion Criteria

Potential candidates for enrollment who meet one or more of t he following criteria are excluded from participation in the study:

  • Self-reported disability in ≥ 2 or more Activities of Daily Living (ADL)
  • Self-reported hearing aid use in the past year (>5 hours/week).
  • Vision impairment (worse than 20/40 on MN Near Vision Card).
  • Medical contraindication to use of hearing aids (e.g., draining ear).
  • Conductive hearing impairment as determined by a difference in air audiometry and bone audiometry ("air-bone gap") greater than 15 dB in 2 or more contiguous frequencies in both ears.
  • Unwilling to wear hearing aids on a regular (i.e., daily or near daily) basis
  • No participants are excluded based on race or sex

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT02412254

Layout table for location information
United States, Maryland
Johns Hopkins Comstock Center for Public Health Research
Hagerstown, Maryland, United States, 21740
Sponsors and Collaborators
Johns Hopkins University
Layout table for investigator information
Principal Investigator: Frank Lin Johns Hopkins University

Publications automatically indexed to this study by Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Johns Hopkins University Identifier: NCT02412254     History of Changes
Other Study ID Numbers: IRB00067383
First Posted: April 9, 2015    Key Record Dates
Last Update Posted: February 11, 2019
Last Verified: February 2019

Additional relevant MeSH terms:
Layout table for MeSH terms
Hearing Loss
Hearing Disorders
Ear Diseases
Otorhinolaryngologic Diseases
Sensation Disorders
Neurologic Manifestations
Nervous System Diseases
Signs and Symptoms